Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief
September 2, 2014Zogenix announced new post-hoc analysis data showing that 12-hour dose of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, provided durable pain relief over the entire dosing interval.
More »
VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer
September 2, 2014VentiRx announced that the U.S. FDA has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for treatment of women with ovarian cancer.
More »
Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors
August 26, 2014Durata Therapeutics announced that Wendy Yarno and Marty Carroll were added to its Board of Directors at a quarterly meeting of the Board.
More »